{"filings":[{"id":649238,"accession_number":"0001849253-26-000031","cik":1849253,"company_name":"RYAN SPECIALTY HOLDINGS, INC.","ticker":"RYAN","form_type":"8-K","filed_at":"2026-05-26T11:15:13+00:00","items":["7.01","9.01"],"status":"ready","headline":"Ryan Specialty boosts buyback authorization by $300M to $600M total","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Board increased share repurchase program by $300M on May 21, 2026; total authorization now $600M.","Company repurchased $260M of Class A common stock in Q2 2026, exhausting prior $300M authorization.","After increase, $300M of authorization remains available as of May 22, 2026.","Founder and Executive Chairman Patrick G. Ryan cited Board's confidence in long-term strategy.","Repurchases may be made via open market, negotiated trades, or Rule 10b5-1 plans."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":8566294272.518191,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":96204,"accession_number":"0001849253-26-000029","cik":1849253,"company_name":"RYAN SPECIALTY HOLDINGS, INC.","ticker":"RYAN","form_type":"8-K","filed_at":"2026-05-01T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Ryan Specialty shareholders elect directors, ratify auditor, approve say-on-pay at 2026 annual meeting","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All six director nominees elected; David P. Bolger received ~1.23B for, ~2.91M against.","Ratification of Deloitte & Touche as auditor for FY 2026 passed with ~1.25B for, ~106K against.","Advisory vote on executive compensation approved: ~1.24B for, ~203K against."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.05,"calibrated_materiality_score":0.05,"market_cap_usd":8566294272.518191,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":96203,"accession_number":"0001849253-26-000023","cik":1849253,"company_name":"RYAN SPECIALTY HOLDINGS, INC.","ticker":"RYAN","form_type":"8-K","filed_at":"2026-04-30T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Ryan Specialty enters option settlement for up to $52.3M share repurchases","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Trust to sell up to ~$52.3M of Class A common stock to company at May 4 closing price.","Repurchases offset share issuance from employee stock options granted on May 5, 2026.","Options vest over 3 years starting July 2029, expire 2036; agreement runs through June 2036.","Purpose is to keep outstanding share count net neutral while incentivizing employees.","Repurchased shares will be cancelled and retired."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"market_cap_usd":8566294272.518191,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":96202,"accession_number":"0001849253-26-000022","cik":1849253,"company_name":"RYAN SPECIALTY HOLDINGS, INC.","ticker":"RYAN","form_type":"8-K","filed_at":"2026-04-30T23:59:59+00:00","items":["2.02","8.01","9.01"],"status":"ready","headline":"Ryan Specialty Q1 revenue up 15.2%; net income $40.6M vs prior-year loss","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total revenue $795.2M (+15.2% YoY); organic growth 11.8%, down from 12.9% prior-year.","Net income $40.6M ($0.13 diluted EPS) vs $(4.4M) loss in prior-year; adjusted diluted EPS $0.47 (+20.5%).","Adjusted EBITDAC $232.0M (+15.7%); margin 29.2% vs 29.1% prior-year.","Board declared $0.13/share quarterly dividend, payable May 26 to holders of record May 12; repurchased $40M of stock."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":795229000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":8566294272.518191,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":109896,"accession_number":"0001849253-26-000004","cik":1849253,"company_name":"RYAN SPECIALTY HOLDINGS, INC.","ticker":"RYAN","form_type":"8-K","filed_at":"2026-02-12T23:59:59+00:00","items":["2.02","2.05","7.01","8.01","9.01"],"status":"ready","headline":"Ryan Specialty Q4 revenue +13% to $751M; net income down 27%; announces $300M buyback and restructuring","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $751.2M (+13.2% YoY); organic growth 6.6% vs 11.0% prior year.","Q4 net income $31.2M (-26.6%); GAAP EPS $0.06; adjusted EPS $0.45 (flat YoY).","Board approved three-year 'Empower Program' with ~$160M pre-tax charges, targeting $80M annual savings by 2029.","$300M share repurchase program authorized; quarterly dividend $0.13 payable March 10, 2026.","FY 2025 revenue $3.05B (+21.3%); adjusted EBITDAC $966.7M (+19.2%); adjusted EPS $1.96 (+9.5%)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":3051126000.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":8566294272.518191,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":109895,"accession_number":"0001628280-26-007479","cik":1849253,"company_name":"RYAN SPECIALTY HOLDINGS, INC.","ticker":"RYAN","form_type":"8-K","filed_at":"2026-02-12T23:59:59+00:00","items":["5.08","8.01"],"status":"ready","headline":"Ryan Specialty sets 2026 annual meeting for April 28; record date March 2","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Annual meeting date: April 28, 2026; held virtually.","Record date for voting: March 2, 2026.","Rule 14a-8 proposals due by February 22, 2026.","Director nominations and other proposals due by February 20, 2026.","Company address for submissions: 155 N. Wacker Dr., Suite 4000, Chicago, IL."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":8566294272.518191,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":126455,"accession_number":"0001849253-25-000018","cik":1849253,"company_name":"RYAN SPECIALTY HOLDINGS, INC.","ticker":"RYAN","form_type":"8-K","filed_at":"2025-12-08T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Board member Bobby Le Blanc to retire Feb. 11, 2026 after Onex sells stake","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Robert Le Blanc, Onex CEO, retires from Ryan Specialty Board effective February 11, 2026; mutual agreement.","Departure follows Onex's sale of its remaining shares in Ryan Specialty; no disagreement with the Company.","Le Blanc's tenure on Compensation and Governance Committee also ends on same date.","Company expresses gratitude for his service since 2018, originally as Onex nominee."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"market_cap_usd":8566294272.518191,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":126454,"accession_number":"0001849253-25-000013","cik":1849253,"company_name":"RYAN SPECIALTY HOLDINGS, INC.","ticker":"RYAN","form_type":"8-K","filed_at":"2025-10-30T23:59:59+00:00","items":["2.02","8.01","9.01"],"status":"ready","headline":"Ryan Specialty Q3 revenue up 24.8% to $754.6M, organic +15.0%, net income $62.6M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total revenue $754.6M, +24.8% YoY; organic growth 15.0% (vs 11.8% prior-year).","Net income $62.6M, +118.6% YoY; adjusted diluted EPS $0.47, +14.6%.","Adjusted EBITDAC $235.5M, +23.8%; margin 31.2%.","Board declared $0.12/share quarterly dividend, payable Nov 25, 2025 to holders of record Nov 11.","Strong contribution from recent M&A; continued strategic investments in talent and technology."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":2299913000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":8566294272.518191,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":126453,"accession_number":"0001849253-25-000008","cik":1849253,"company_name":"RYAN SPECIALTY HOLDINGS, INC.","ticker":"RYAN","form_type":"8-K","filed_at":"2025-10-08T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Ryan Specialty appoints Keogh and Mulshine as Co-Presidents; Bickham advisor","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Stephen P. Keogh named Co-President and COO; Brendan M. Mulshine named Co-President and CRO.","Appointments effective Oct 9, 2025; both report to CEO Tim Turner.","Jeremiah Bickham transitions from President to non-employee strategic advisor through Jan 1, 2026.","Bickham had been with Ryan Specialty for nearly 14 years; Keogh joined in May 2025.","Mulshine has been with the firm since 2012; both have over 30 years of insurance industry experience."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":8566294272.518191,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":143200,"accession_number":"0001849253-25-000004","cik":1849253,"company_name":"RYAN SPECIALTY HOLDINGS, INC.","ticker":"RYAN","form_type":"8-K","filed_at":"2025-09-09T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Ryan Specialty elects Michael G. Bungert to board; former Aon Re Chairman","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Michael G. Bungert joined board effective Sept 3, 2025; assigned to Compensation and Governance Committee.","Bungert retired as Chairman of Aon Re Global in 2024 after 11-year tenure; 40+ years in reinsurance.","Initial term expires at 2026 annual meeting; will receive $200k prorated RSU grant (vests immediately) and $120k annual cash retainer.","No related transactions or arrangements requiring disclosure under Item 404(a)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":8566294272.518191,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":143199,"accession_number":"0001628280-25-036997","cik":1849253,"company_name":"RYAN SPECIALTY HOLDINGS, INC.","ticker":"RYAN","form_type":"8-K","filed_at":"2025-07-31T23:59:59+00:00","items":["2.02","8.01","9.01"],"status":"ready","headline":"Ryan Specialty Q2 total revenue $855.2M, +23% YoY; Adj. EPS $0.66, +13.8%; declares $0.12 dividend","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total revenue $855.2M (+23.0% YoY); organic revenue growth 7.1% decelerated from 14.2%.","Net income $124.7M (+5.6%); adjusted net income $184.7M (+15.0%); adjusted diluted EPS $0.66 (+13.8%).","Adjusted EBITDAC $308.4M (+24.5%); margin 36.1% expanded 50 bps YoY.","Board declared $0.12/share quarterly dividend, payable Aug 26 to holders of record Aug 12.","Completed three acquisitions in recent months to strengthen delegated authority capabilities."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":1545336000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":8566294272.518191,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":143198,"accession_number":"0001628280-25-035218","cik":1849253,"company_name":"RYAN SPECIALTY HOLDINGS, INC.","ticker":"RYAN","form_type":"8-K","filed_at":"2025-07-17T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Ryan Specialty board lead director Cam Findlay dies; successors named","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["D. Cameron Findlay, board member since 2012 and Lead Director, passed away unexpectedly in July 2025.","Board appointed John W. Rogers, Jr. as Lead Director and Henry S. Bienen as Chair of Compensation & Governance Committee.","Findlay previously served as GC at Archer Daniels Midland, Medtronic, and Aon, and in White House and Labor Dept. roles."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":8566294272.518191,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":161332,"accession_number":"0001628280-25-029168","cik":1849253,"company_name":"RYAN SPECIALTY HOLDINGS, INC.","ticker":"RYAN","form_type":"8-K","filed_at":"2025-06-04T23:59:59+00:00","items":["3.03","5.03","5.07","9.01"],"status":"ready","headline":"Ryan Specialty stockholders approve governance overhaul including Class B vote sunset by Sept 2029","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Stockholders approved declassification of Board and phase-in of annual director elections; four nominees elected to three-year terms expiring 2028.","Class B common stock's 10-to-1 voting disparity will sunset on September 30, 2029, equalizing voting power with Class A.","Stockholders granted rights to act by written consent and to call special meetings, enhancing shareholder democracy.","Supermajority voting requirements eliminated for director removal and charter/bylaw amendments; majority standard applies going forward.","Officer exculpation provision adopted to maximum extent under Delaware law, reducing personal liability risk for officers."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":8566294272.518191,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":161331,"accession_number":"0001628280-25-021523","cik":1849253,"company_name":"RYAN SPECIALTY HOLDINGS, INC.","ticker":"RYAN","form_type":"8-K","filed_at":"2025-05-01T23:59:59+00:00","items":["2.02","8.01","9.01"],"status":"ready","headline":"Ryan Specialty Q1 rev up 25% to $690M; GAAP net loss $4.4M; declares $0.12 dividend","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total revenue $690.2M (+25% YoY); organic growth 12.9%.","GAAP net loss $(4.4)M vs $40.7M income in Q1 2024; diluted loss $(0.22) per share.","Adjusted EBITDAC $200.5M (+27.5%), margin 29.1%; adjusted diluted EPS $0.39 (+11.4%).","Quarterly dividend of $0.12 per share declared; payable May 27, 2025 to holders of record May 13, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":690166000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":8566294272.518191,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":179492,"accession_number":"0001628280-25-015192","cik":1849253,"company_name":"RYAN SPECIALTY HOLDINGS, INC.","ticker":"RYAN","form_type":"8-K","filed_at":"2025-03-27T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Ryan Specialty appoints Steve Keogh as COO effective May 1, 2025","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Keogh was Senior Advisor to Aon's Office of President and formerly President of Aon's Commercial Risk Solutions.","Base salary of $600,000; annual bonus target of 150% of base under Executive Incentive Corporate Plan.","Initial PSU grant of $2M vesting July 1, 2030 subject to organic revenue CAGR and stock price CAGR targets.","Keogh brings over 32 years of experience at Aon in operations, finance, tech, and executive management."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":8566294272.518191,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":179491,"accession_number":"0001628280-25-006736","cik":1849253,"company_name":"RYAN SPECIALTY HOLDINGS, INC.","ticker":"RYAN","form_type":"8-K","filed_at":"2025-02-20T23:59:59+00:00","items":["2.02","8.01","9.01"],"status":"ready","headline":"Ryan Specialty Q4 revenue up 24.5% to $663.5M; Adj. EBITDAC +36.2%; declares $0.12 dividend","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total revenue $663.5M (+24.5% YoY); organic growth 11.0% (vs 16.5% prior year).","Adjusted EBITDAC $216.0M (+36.2%); margin 32.6% vs 29.8%.","GAAP net income $42.6M (-27.3% YoY); adjusted diluted EPS $0.45 (+28.6%).","Board declared regular quarterly dividend $0.12/share, payable March 18, 2025 to holders of record March 4, 2025.","FY2024 revenue $2.5B (+21.1%); 7 acquisitions closed in 2024; recent acquisition of Velocity Risk Underwriters in Jan 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":2515710000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":8566294272.518191,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":196210,"accession_number":"0001193125-24-273411","cik":1849253,"company_name":"RYAN SPECIALTY HOLDINGS, INC.","ticker":"RYAN","form_type":"8-K","filed_at":"2024-12-09T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Ryan Specialty Issues $600 Million Additional 5.875% Senior Secured Notes Due 2032","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Issued $600M aggregate principal amount of additional 5.875% Senior Secured Notes due 2032 on Dec 9, 2024.","Net proceeds will be used for future acquisition opportunities and investments and general corporate purposes.","Part of proceeds temporarily repay up to $400M of borrowings under Revolving Credit Facility used to fund Innovisk Capital Partners acquisition.","Notes issued at 99.500% of principal amount under first supplemental indenture with U.S. Bank Trust Company as trustee."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":8566294272.518191,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":196209,"accession_number":"0001193125-24-269037","cik":1849253,"company_name":"RYAN SPECIALTY HOLDINGS, INC.","ticker":"RYAN","form_type":"8-K","filed_at":"2024-12-02T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Ryan Specialty upsizes and prices $600M of 5.875% senior secured notes due 2032","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Offering increased by $100M from previously announced $500M; priced at 99.5% of par.","Closing expected on Dec 9, 2024; notes are additional under indenture for $600M existing 5.875% notes.","Proceeds for future acquisitions, general corporate; may temporarily repay up to $400M of revolver used for Innovisk Capital Partners acquisition.","Notes are secured first-lien, guaranteed by subsidiary guarantors, not by Ryan Specialty Holdings.","Innovisk Capital Partners acquisition closed Nov 4, 2024 for $450M."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":8566294272.518191,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":196208,"accession_number":"0001193125-24-268454","cik":1849253,"company_name":"RYAN SPECIALTY HOLDINGS, INC.","ticker":"RYAN","form_type":"8-K","filed_at":"2024-12-02T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Ryan Specialty launches $500M add-on to 5.875% senior secured notes due 2032","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Up to $500M aggregate principal of additional 5.875% senior secured notes due 2032 in a private offering.","New notes are additional issuance under indenture governing existing $600M of 5.875% notes issued Sept 2024.","Proceeds for future acquisitions, general corporate purposes, and may repay up to $400M of revolver borrowings.","Revolver borrowings funded part of $450M acquisition of Innovisk Capital Partners on Nov 4, 2024.","Notes are senior secured, guaranteed by wholly owned subsidiaries, but not by Ryan Specialty Holdings."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":8566294272.518191,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":196207,"accession_number":"0001628280-24-044311","cik":1849253,"company_name":"RYAN SPECIALTY HOLDINGS, INC.","ticker":"RYAN","form_type":"8-K","filed_at":"2024-10-30T23:59:59+00:00","items":["2.02","8.01","9.01"],"status":"ready","headline":"Ryan Specialty Q3 revenue up 20.5% to $604.7M; adj. EPS $0.41 beats prior year by 28%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total revenue $604.7M (+20.5% YoY); organic revenue growth 11.8% (vs 15.0% prior year).","Net income $28.6M ($0.09 diluted EPS), up 82.4% YoY; adjusted net income $113.6M ($0.41 adj. diluted EPS, +28% YoY).","Adjusted EBITDAC $190.3M (+29.4% YoY), margin expanded 220 bps to 31.5%.","CEO transition: Tim Turner took over as CEO; Patrick Ryan remains Executive Chairman.","Board declared $0.11/share quarterly dividend, payable Nov 26 to holders of record Nov 12."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":1852181000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":8566294272.518191,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":212494,"accession_number":"0000950170-24-108156","cik":1849253,"company_name":"RYAN SPECIALTY HOLDINGS, INC.","ticker":"RYAN","form_type":"8-K","filed_at":"2024-09-19T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Ryan Specialty refinances $1.588B term loan, issues $600M 5.875% notes due 2032","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Refinanced existing $1.5881B term loan; added $111.875M incremental term loan at SOFR+2.25% (down 50 bps).","Net proceeds from $600M 5.875% senior secured notes due 2032 used to repay revolver borrowings funding US Assure acquisition.","Term loan matures Sept 13, 2031; revolver matures July 30, 2029; notes mature Aug 1, 2032.","US Assure acquisition closed Aug 30, 2024 for approx $1.075B; funded with revolver borrowings and cash."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":8566294272.518191,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":212493,"accession_number":"0001193125-24-214267","cik":1849253,"company_name":"RYAN SPECIALTY HOLDINGS, INC.","ticker":"RYAN","form_type":"8-K","filed_at":"2024-09-05T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Ryan Specialty upsizes and prices $600M Senior Secured Notes at 5.875% due 2032","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Priced $600M aggregate principal of 5.875% Senior Secured Notes due 2032 at 100% of par.","Offering upsized by $100M from previously announced size; closing expected Sept 19, 2024.","Net proceeds to repay revolver borrowings used to fund the $1.075B acquisition of US Assure Insurance Services.","Notes are senior secured, jointly guaranteed by subsidiary guarantors, but not by Ryan Specialty Holdings."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":8566294272.518191,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":212492,"accession_number":"0001193125-24-213713","cik":1849253,"company_name":"RYAN SPECIALTY HOLDINGS, INC.","ticker":"RYAN","form_type":"8-K","filed_at":"2024-09-05T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Ryan Specialty proposes $500M senior secured notes offering; plans $1.7B term loan refinancing","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Ryan Specialty, LLC offers $500M senior secured notes due 2032 to repay revolving credit borrowings used for US Assure acquisition.","Concurrently, company commences refinancing existing $1.6B term loan with new up to $1.7B term loan facility.","US Assure acquisition was consummated on Aug 30, 2024 for approx $1.075B.","Notes are secured by substantially all assets that secure existing notes/credit facilities; not guaranteed by parent Ryan Specialty Holdings.","Offering is private to QIBs and non-US persons under Rule 144A/Reg S; no registration under Securities Act."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":8566294272.518191,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":212491,"accession_number":"0000950170-24-102557","cik":1849253,"company_name":"RYAN SPECIALTY HOLDINGS, INC.","ticker":"RYAN","form_type":"8-K","filed_at":"2024-09-03T23:59:59+00:00","items":["2.03","7.01","8.01","9.01"],"status":"ready","headline":"Ryan Specialty completes acquisition of US Assure for $1.075B cash plus up to $400M earnout","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Acquisition closed Aug 30 for $1.075B cash plus up to $400M earnout based on performance targets.","Borrowed $850M under revolver at SOFR+2.25% to partially fund acquisition; bridge facility not used.","US Assure is a leading program specializing in builder's risk insurance; will be part of Underwriting Managers Specialty.","Revolving credit facility has $549.6M undrawn capacity after borrowing; matures in 2029."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":8566294272.518191,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":212490,"accession_number":"0000950170-24-089273","cik":1849253,"company_name":"RYAN SPECIALTY HOLDINGS, INC.","ticker":"RYAN","form_type":"8-K","filed_at":"2024-08-01T23:59:59+00:00","items":["1.01","2.03","7.01","8.01","9.01"],"status":"ready","headline":"Ryan Specialty to acquire US Assure for ~$1.075B plus up to $400M earnout","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Acquisition of US Assure for $1.075B in cash plus up to $400M earnout based on 3-year performance targets.","Expected to close Q3 2024; US Assure will become part of Ryan Specialty Underwriting Managers.","Financing includes $500M bridge loan and revolver upsized from $600M to $1.4B.","US Assure is a builder's risk program with 20,000+ active agents and proprietary technology platform.","Zurich American remains the carrier providing same program capacity and underwriting guidelines."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.9,"calibrated_materiality_score":0.9,"market_cap_usd":8566294272.518191,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":212489,"accession_number":"0000950170-24-089264","cik":1849253,"company_name":"RYAN SPECIALTY HOLDINGS, INC.","ticker":"RYAN","form_type":"8-K","filed_at":"2024-08-01T23:59:59+00:00","items":["2.02","8.01","9.01"],"status":"ready","headline":"Ryan Specialty Q2 revenue $695M (+18.8%), acquires US Assure, CEO succession","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $695.4M (+18.8% YoY); organic growth 14.2%; Net income $118M ($0.37 diluted EPS).","Adjusted EBITDAC $247.7M (+27.6%); margin 35.6% (up 240bps vs 33.2%).","Announces acquisition of US Assure, a program focused on SME builder's risk; expected to be accretive.","CEO Patrick Ryan to be succeeded by Tim Turner in October; board declares $0.11/share dividend payable Aug 27."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":1247487000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":8566294272.518191,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":212488,"accession_number":"0000950170-24-079273","cik":1849253,"company_name":"RYAN SPECIALTY HOLDINGS, INC.","ticker":"RYAN","form_type":"8-K","filed_at":"2024-07-01T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Ryan Specialty CEO succession: Pat Ryan becomes Exec Chairman, Tim Turner becomes CEO, effective Oct 1, 2024","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Founder/Chairman/CEO Pat Ryan (age 87) transitions to Executive Chairman, continuing as executive officer.","Tim Turner (President, Chairman/CEO of RT Specialty) becomes CEO; remains on Board.","CFO Jeremiah Bickham becomes President of Ryan Specialty.","Chief Accounting Officer Janice Hamilton becomes CFO.","Succession approved by Board on June 28, 2024, effective October 1, 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":8566294272.518191,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":231442,"accession_number":"0000950170-24-054869","cik":1849253,"company_name":"RYAN SPECIALTY HOLDINGS, INC.","ticker":"RYAN","form_type":"8-K","filed_at":"2024-05-08T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Ryan Specialty stockholders elect directors and approve auditor and executive compensation at annual meeting","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Elected Patrick G. Ryan, Michelle L. Collins, D. Cameron Findlay, John W. Rogers, Jr. to Board through 2027.","Elected Francesca Cornelli and Anthony J. Kuczinski to Board through 2026; Patrick G. Ryan, Jr. through 2025.","Ratified Deloitte & Touche LLP as independent auditor for FY2024 with over 1.3 billion votes for.","Advisory vote on named executive officer compensation approved with 1.28 billion votes for."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"market_cap_usd":8566294272.518191,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":231441,"accession_number":"0000950170-24-052148","cik":1849253,"company_name":"RYAN SPECIALTY HOLDINGS, INC.","ticker":"RYAN","form_type":"8-K","filed_at":"2024-05-02T23:59:59+00:00","items":["2.02","8.01","9.01"],"status":"ready","headline":"Ryan Specialty Q1 revenue $552M (+20.6% YoY); adj. EPS $0.35 (+34.6%)","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total revenue $552.0M, up 20.6% YoY; organic revenue growth 13.7% vs. 13.4% prior year.","Net income $40.7M, +11.6% YoY; adjusted net income $95.4M, +32.9% YoY.","Adjusted EBITDAC $157.2M, +25.8% YoY; margin expanded 120 bps to 28.5%.","Adjusted diluted EPS $0.35, up 34.6% YoY; regular quarterly dividend of $0.11/share declared.","Completed acquisition of Castel on May 1, 2024, adding international delegated authority capability."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":552046000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":8566294272.518191,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":249830,"accession_number":"0000950170-24-021174","cik":1849253,"company_name":"RYAN SPECIALTY HOLDINGS, INC.","ticker":"RYAN","form_type":"8-K","filed_at":"2024-02-27T23:59:59+00:00","items":["2.02","8.01","9.01"],"status":"ready","headline":"Ryan Specialty Q4 revenue $532.9M (+22.5% YoY); initiates $0.11 quarterly dividend","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total revenue $532.9M (+22.5% YoY); organic revenue growth 16.0% (vs 10.3% prior year).","Net income $58.5M ($0.18 diluted); adjusted net income $95.7M, adjusted diluted EPS $0.35 (+29.6% YoY).","Adjusted EBITDAC $158.6M (+24.6% YoY); margin 29.8% (vs 29.3% prior year).","Board declares one-time special dividend $0.23/share and initiates regular quarterly dividend $0.11/share, payable March 27, 2024.","Full year 2023 revenue $2,077.5M (+20.4% YoY); adjusted diluted EPS $1.38 (+20.0% YoY)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":2077549000.0,"consensus_period":"2023-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":8566294272.518191,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":249829,"accession_number":"0000950170-24-005584","cik":1849253,"company_name":"RYAN SPECIALTY HOLDINGS, INC.","ticker":"RYAN","form_type":"8-K","filed_at":"2024-01-19T23:59:59+00:00","items":["1.01","8.01","9.01"],"status":"ready","headline":"Ryan Specialty reprices $1.65B term loan, cuts rate 25 bps to SOFR+2.75%, saves ~$5.6M/yr","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Term loan interest rate reduced from SOFR+3.00% to SOFR+2.75%; credit spread adjustment eliminated.","Expected annual cash interest savings of approximately $5.6 million.","Maturity date of September 2027 and all other material terms remain unchanged.","Repricing executed via fifth amendment to credit agreement with JPMorgan-led syndicate."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":8566294272.518191,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":249828,"accession_number":"0000950170-24-000331","cik":1849253,"company_name":"RYAN SPECIALTY HOLDINGS, INC.","ticker":"RYAN","form_type":"8-K","filed_at":"2024-01-02T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Ryan Specialty board changes: Devers retires; Pat Ryan Jr. appointed","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["William J. Devers retired from board effective Dec 31, 2023 after 11 years; no disagreement.","Patrick G. Ryan Jr., CEO of Incisent Labs Group and tech entrepreneur, elected effective Jan 1, 2024.","Pat Ryan Jr. is son of CEO/Chairman Patrick G. Ryan; appointment under Director Nomination Agreement.","New director receives prorated $125k RSU grant (fully vested) and $100k annual cash retainer.","Standard indemnification agreement to be entered with Pat Ryan Jr."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":8566294272.518191,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":267306,"accession_number":"0000950170-23-058239","cik":1849253,"company_name":"RYAN SPECIALTY HOLDINGS, INC.","ticker":"RYAN","form_type":"8-K","filed_at":"2023-11-02T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Ryan Specialty Q3 revenue up 21.8% to $502M; adj. diluted EPS $0.32 beats prior year","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total revenue $501.9M, up 21.8% YoY; organic growth rate 14.7%.","Net income $15.7M vs $29.3M YoY; GAAP diluted loss per share $(0.04) due to discrete deferred tax expense.","Adjusted EBITDAC $147.0M, up 25.8%; margin expanded to 29.3% from 28.4%.","Adjusted net income $86.6M, up 30.2%; adjusted diluted EPS $0.32, up 28.0%.","Agreed to acquire AccuRisk to expand benefits practice; three acquisitions closed in July 2023."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":1544686000.0,"consensus_period":"2023-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":8566294272.518191,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":267305,"accession_number":"0000950170-23-056916","cik":1849253,"company_name":"RYAN SPECIALTY HOLDINGS, INC.","ticker":"RYAN","form_type":"8-K","filed_at":"2023-10-31T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Ryan Specialty adds former Munich Re US CEO Anthony Kuczinski to Board","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Anthony J. Kuczinski elected to Board, serves on Compensation & Governance Committee, effective Oct 30, 2023.","Kuczinski has 38+ years of (re)insurance experience, including 15 years as President & CEO of Munich Reinsurance US.","Receives prorated RSU grant of $120K fair value and $85K annual cash retainer, paid quarterly.","Board expands to 13 members; Kuczinski is independent under NYSE and SEC rules."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":8566294272.518191,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":284567,"accession_number":"0000950170-23-038034","cik":1849253,"company_name":"RYAN SPECIALTY HOLDINGS, INC.","ticker":"RYAN","form_type":"8-K","filed_at":"2023-08-03T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Ryan Specialty reports Q2 2023 revenue up 19.1% to $585.1M; adjusted diluted EPS $0.45","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $585.1M, +19.1% YoY; organic growth 16.1% (prior-year 22.3%).","Net income $83.8M ($0.26 diluted EPS); adjusted net income $123.7M ($0.45 adjusted diluted EPS).","Adjusted EBITDAC $194.2M (+16.9% YoY); margin 33.2% (prior 33.8%).","Company announced key acquisitions including first in employee benefits; progress on ACCELERATE 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":1042748000.0,"consensus_period":"2023-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":8566294272.518191,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":284566,"accession_number":"0000950170-23-035977","cik":1849253,"company_name":"RYAN SPECIALTY HOLDINGS, INC.","ticker":"RYAN","form_type":"8-K","filed_at":"2023-07-31T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Ryan Specialty appoints Francesca Cornelli, Kellogg Dean, to Board of Directors","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Francesca Cornelli, Dean of Northwestern's Kellogg School, appointed to board effective July 31, 2023.","Dr. Cornelli will serve on the Audit Committee; Henry S. Bienen moves to Compensation and Governance Committee.","Board size increases to 12 members with her election.","Dr. Cornelli will receive $120K in RSUs (prorated) and $85K annual cash retainer under standard director compensation.","She previously served on boards of Swiss Re International and Swiss Re Europe (2013-2019)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":8566294272.518191,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":304294,"accession_number":"0001193125-23-152962","cik":1849253,"company_name":"RYAN SPECIALTY HOLDINGS, INC.","ticker":"RYAN","form_type":"8-K","filed_at":"2023-05-24T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Selling shareholders to sell 9M shares of Ryan Specialty at $43.45 in secondary offering","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["9,000,000 shares sold by selling shareholders at $43.45/share; company receives no proceeds.","Underwriter is Barclays Capital Inc.; shares expected to deliver on May 25, 2023.","Registration filed on Form S-3ASR on May 22, 2023; estimated offering expenses $1,100,637.","Underwriting agreement contains customary representations, warranties, and indemnification.","Selling shareholders are named in Schedule 2 to the agreement, not explicitly identified."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":8566294272.518191,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":304293,"accession_number":"0000950170-23-018078","cik":1849253,"company_name":"RYAN SPECIALTY HOLDINGS, INC.","ticker":"RYAN","form_type":"8-K","filed_at":"2023-05-05T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Ryan Specialty shareholders elect directors, ratify auditor, approve executive compensation at 2023 annual meeting","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["David P. Bolger, Nicholas D. Cortezi, and Robert Le Blanc elected directors with over 1.245 billion votes each.","Ratification of Deloitte & Touche LLP as independent auditor for FY 2023 approved: 1.294 billion for, 0.15 million against.","Advisory vote on named executive officer compensation approved: 1.275 billion for, 6.3 million against, 0.1 million abstentions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"market_cap_usd":8566294272.518191,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":304292,"accession_number":"0000950170-23-017896","cik":1849253,"company_name":"RYAN SPECIALTY HOLDINGS, INC.","ticker":"RYAN","form_type":"8-K","filed_at":"2023-05-04T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Ryan Specialty Q1 revenue up 18.3% to $457.6M; net income doubles to $36.5M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total revenue $457.6M (+18.3% YoY); organic growth 12.9%.","Net income $36.5M (vs $18.1M), diluted EPS $0.11; adjusted diluted EPS $0.26 (+8.3%).","Adjusted EBITDAC $125.0M (+16.5%), margin 27.3% vs 27.7% prior year.","CEO notes broad-based growth led by Property in historically hard market."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":457599000.0,"consensus_period":"2023-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":8566294272.518191,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":323923,"accession_number":"0000950170-23-007023","cik":1849253,"company_name":"RYAN SPECIALTY HOLDINGS, INC.","ticker":"RYAN","form_type":"8-K","filed_at":"2023-03-09T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Ryan Specialty Promotes Michael VanAcker to EVP of RT Specialty","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Michael T. VanAcker moves from Chief Operating Officer to Executive Vice President of RT Specialty, effective March 9, 2023.","VanAcker has over 10 years of experience at Ryan Specialty, previously serving as COO and RT Specialty's COO and Controller.","He was integral to Ryan Specialty's M&A activity, acquisition integration, and the firm's growth trajectory.","VanAcker will work closely with Tim Turner, Chairman & CEO of RT Specialty, and Ed McCormack, President of RT Specialty."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":8566294272.518191,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":323922,"accession_number":"0000950170-23-005117","cik":1849253,"company_name":"RYAN SPECIALTY HOLDINGS, INC.","ticker":"RYAN","form_type":"8-K","filed_at":"2023-02-28T23:59:59+00:00","items":["2.02","2.05","9.01"],"status":"ready","headline":"Ryan Specialty announces restructuring program with $65M charges, $35M annual savings; Q4 results released","summary_kind":"llm","event_type":"other_material","confidence":"medium","bullets":["Board approved two-year restructuring program starting Q1 2023, expected to generate $35M annual cost savings by 2025.","Cumulative pre-tax charges estimated at $65M: $45M operations/tech optimization, $15M compensation/benefits, $5M asset impairment.","Approximately 95% of restructuring charges will result in future cash expenditures; program to be completed by end of 2024.","Company also issued Q4 2022 earnings press release on Feb 28, 2023, but no specific financial results provided in this filing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":8566294272.518191,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":323921,"accession_number":"0000950170-23-004246","cik":1849253,"company_name":"RYAN SPECIALTY HOLDINGS, INC.","ticker":"RYAN","form_type":"8-K","filed_at":"2023-02-24T23:59:59+00:00","items":["5.08","8.01"],"status":"ready","headline":"Ryan Specialty sets 2023 annual meeting for May 1; record date March 10, proposal deadline March 6","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Annual meeting of stockholders scheduled for May 1, 2023, held virtually.","Record date for voting eligibility is close of business on March 10, 2023.","Deadline for Rule 14a-8 stockholder proposals is March 6, 2023.","Advance notice deadline for director nominations and other proposals is March 6, 2023."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":8566294272.518191,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":341906,"accession_number":"0000950170-22-024500","cik":1849253,"company_name":"RYAN SPECIALTY HOLDINGS, INC.","ticker":"RYAN","form_type":"8-K","filed_at":"2022-11-10T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Ryan Specialty Q3 2022 earnings reported; confidence low due to missing exhibit details","summary_kind":"llm","event_type":"earnings","confidence":"low","bullets":["Q3 2022 earnings press release issued on Nov 10, 2022, but Exhibit 99.1 not included in filing text.","No specific financial data (revenue, EPS, segment results) are available from the provided text.","Confidence low; materiality cannot be assessed without the press release."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":1290178000.0,"consensus_period":"2022-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":8566294272.518191,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":358749,"accession_number":"0000950170-22-016888","cik":1849253,"company_name":"RYAN SPECIALTY HOLDINGS, INC.","ticker":"RYAN","form_type":"8-K","filed_at":"2022-08-11T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Ryan Specialty Q2 revenue up 26% to $491M; organic growth 22.3%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net income $70.1M ($0.22 diluted EPS); adjusted net income $106.4M ($0.39 adjusted EPS).","Adjusted EBITDAC $166.1M, up 18.2% YoY; margin 33.8% vs 36.0% prior year.","Total revenue $491.3M, up 26.0% YoY; organic revenue growth 22.3%.","Compensation and benefits ratio 63.1% vs 60.7% prior year; G&A ratio 9.9% vs 7.9%.","CEO Patrick Ryan cites continued strength; no explicit guidance change provided."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":878182000.0,"consensus_period":"2022-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":8566294272.518191,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":377500,"accession_number":"0000950170-22-011574","cik":1849253,"company_name":"RYAN SPECIALTY HOLDINGS, INC.","ticker":"RYAN","form_type":"8-K","filed_at":"2022-06-13T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Ryan Specialty stockholders elect four directors and approve all six proposals at 2022 annual meeting","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Directors Bienen, Devers, O'Halleran, and Turner elected with over 97% of votes cast.","Ratification of Deloitte & Touche as auditor for FY2022 approved with 1.306 billion votes for.","Advisory say-on-pay passed with ~1.268 billion votes for; company will continue annual advisory votes.","Retention of supermajority standards and classified board structure both approved on advisory basis."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":8566294272.518191,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":377499,"accession_number":"0000950170-22-011340","cik":1849253,"company_name":"RYAN SPECIALTY HOLDINGS, INC.","ticker":"RYAN","form_type":"8-K","filed_at":"2022-06-08T23:59:59+00:00","items":["5.03","9.01"],"status":"ready","headline":"Ryan Specialty changes corporate name to Ryan Specialty Holdings, Inc. effective June 6, 2022","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Name changed from Ryan Specialty Group Holdings, Inc. to Ryan Specialty Holdings, Inc.","Amended and Restated Bylaws updated to reflect name change and subsidiary references.","No other changes to certificate of incorporation or bylaws; business operations unaffected.","Name change effective June 6, 2022; new holding company structure adopted September 2021."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":8566294272.518191,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":377498,"accession_number":"0000950170-22-009691","cik":1849253,"company_name":"RYAN SPECIALTY HOLDINGS, INC.","ticker":"RYAN","form_type":"8-K","filed_at":"2022-05-12T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Ryan Specialty Q1 revenue up 24.2% to $386.9M; organic growth 20.1%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net income of $18.1M ($0.06 diluted EPS) vs net loss of $3.8M a year ago.","Adjusted net income rose 13.3% to $64.7M; adjusted diluted EPS $0.24.","Adjusted EBITDAC grew 13.6% to $107.3M; margin 27.7% vs 30.3% prior year.","Organic revenue growth rate accelerated to 20.1% from 18.4% in Q1 2021.","Total operating expenses up 26.5%; compensation ratio increased to 70.9%."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":386890000.0,"consensus_period":"2022-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":8566294272.518191,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":395889,"accession_number":"0000950170-22-003757","cik":1849253,"company_name":"RYAN SPECIALTY HOLDINGS, INC.","ticker":"RYAN","form_type":"8-K","filed_at":"2022-03-15T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Ryan Specialty Q4 total revenue $378.5M (+15.8%), net income $29.6M, adj. EPS $0.29","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total revenue $378.5M (+15.8% YoY); organic revenue growth 15.4%.","Net income $29.6M vs net loss $3.5M in Q4 2020; diluted EPS $0.09.","Adjusted EBITDAC $120.3M (+18.2%); adjusted diluted EPS $0.29.","Full year 2021 revenue $1.4B (+41%), organic growth 22.4%, adj. EBITDAC $460.2M (+56.8%).","Initiates 2022 outlook for organic revenue growth rate and adjusted EBITDAC margin; no specific figures given."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":8566294272.518191,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":395888,"accession_number":"0000950170-22-003585","cik":1849253,"company_name":"RYAN SPECIALTY HOLDINGS, INC.","ticker":"RYAN","form_type":"8-K","filed_at":"2022-03-14T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Ryan Specialty Group adopts Executive Severance Plan for named executive officers","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Severance plan covers named executive officers; effective Dec 31, 2021.","Grade 13 (CEO/President): 1.5x base salary + target bonus on qualified termination; 2.0x on change-in-control.","Grade 12 execs: 1.0x base salary + target bonus on qualified termination; 2.0x on change-in-control.","Benefits include prorated annual bonus and health/welfare coverage lump sum (18 months for grade 13, 12 months for grade 12).","Severance conditioned on non-competition and non-solicitation covenants; excise tax reduction provision included."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":8566294272.518191,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":395887,"accession_number":"0000950170-22-003236","cik":1849253,"company_name":"RYAN SPECIALTY HOLDINGS, INC.","ticker":"RYAN","form_type":"8-K","filed_at":"2022-03-09T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Ryan Specialty Group sets virtual 2022 annual meeting for June 7","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Annual meeting to be held virtually on Tuesday, June 7, 2022.","Record date for stockholders entitled to vote is April 11, 2022.","Meeting format changed to virtual-only; no physical location.","Board of Directors made the determination to adopt virtual format."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":8566294272.518191,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":"2022-03-09T23:59:59+00:00|395887"}